$CBKM

CONSUMERS BANCORP INC /OH/ (CBKM): Results of Operations and Financial Condition

CONSUMERS BANCORP INC /OH/ (CBKM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_994723.htm EXHIBIT 99.1 ex_994723.htm Exhibit 99.1 Consumers Bancorp, Inc. Reports: ● Net income increased by $665 thousand, or 29.0%, for the three-month period and by $2.5 million, or 28.8%, for twelve-month period ended June 30, 2026, compared with the same period

Original reporting
Published Jul 29, 2026, 12:56 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 1:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CBKM
Bullish
medium confidence
Mentioned
$CBKM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CBKMBullishMed
01

Why it matters

Net income rose year over year, driven by higher net interest income and a higher net interest margin, alongside strong loan commitments and deposit growth. Credit quality metrics reported remain very low, supporting the earnings quality narrative.

02

Market read

Traders can reassess CBKM’s earnings power and balance-sheet momentum using the newly disclosed NIM, loan/deposit growth, and nonperforming loan ratio.

03

What to watch

The filing emphasizes low NPLs and limited net charge-offs, but does not quantify unrealized securities losses, funding concentration, or capital ratios, which can matter for risk-adjusted valuation.

Relevance 7/10Novelty 7/10Timing: filed pre-market today on SEC 8-K with Q4 and FY-to-date operating results

Background

The company filed an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting quarterly and twelve-month results ended June 30, 2026.

Company-level read

Ticker impact

$CBKMBullishMedium confidence
Context

Consumers Bancorp reported FY2026 and Q4 FY2026 results on an 8-K, including net income, net interest income, loan growth, and nonperforming loan ratio.

Expected impact

Near-term bias modestly positive for OTC liquidity, but magnitude likely limited versus larger listed banks.

Evidence & confidence

The filing provides fresh, specific operating metrics (net income, EPS, NIM, loans, deposits, NPL ratio, book value) that can change valuation expectations for a small regional/OTC bank, though it lacks forward guidance or capital actions.

Market effects

Adds a datapoint that small-bank net interest income and margins can improve with reinvestment at higher rates and loan mix shifts.

Highlights loan demand and deposit growth in its Ohio footprint, which can influence local credit and funding sentiment.

Low; this is company-specific and OTC-listed with limited direct cross-market read-across.

Counterpoint

Higher earnings may be partly mix-driven (asset yield up, cost of funds down) and could be less durable if rate conditions or prepayment dynamics reverse.

Key entities

  • Consumers Bancorp, Inc.

    OTC-listed bank reporting Q4 FY2026 and FY2026 results ended June 30, 2026.

  • Ralph J. Lober II

    President and CEO cited strong loan demand and ongoing branch and technology investments.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.